Xcout Intel
Splice Bio
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Subscribe to see Splice Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Splice Bio at a glance
Splice Bio is a biotech company headquartered in United States. Xcout tracks 17 named people at Splice Bio, including Donald Munoz (CHIEF FINANCIAL OFFICER). Xcout recorded 12 job postings from Splice Bio in the last 90 days, naming tools such as Claude, Cursor, Fivetran.
Splice Bio leadership
- Donald MunozCHIEF FINANCIAL OFFICER
- Aniz GirachCHIEF MEDICAL OFFICER
- Gerard CaellesCHIEF BUSINESS OFFICER
- Jean-Philippe CombalChairman
- Miquel Vila-PerellóCO-FOUNDER & CEO
- Silvia FrutosCO-FOUNDER & CTO
11 more named people on record for Splice Bio, with roles, board committees and tenure — see the full roster →
Hiring at Splice Bio
Xcout recorded 12 job postings from Splice Bio in the last 90 days, from a hiring record Xcout has kept since August 2026.
Tools named in Splice Bio's job postings
The weekly hiring trend, the roles and locations behind it — see Splice Bio's hiring signals →
Tech stack
Splice Bio competitors
A few of Splice Bio's closest competitors — see the full list of competitors and alternatives →
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Skylark Bio is a biotechnology company developing precision-targeted, locally delivered gene therapies to treat genetic hearing loss and other single-gene disorders. The company's platform aims to restore natural biological processes and hearing function, addressing conditions that affect children and individuals with genetic communication impairments.
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Scribe Therapeutics is a clinical-stage biotechnology company that develops genetic therapies for conditions such as heart disease and has pursued public offerings in the United States.
Arbor Biotechnologies, Inc. is a next-generation gene editing company focused on discovering and developing precise genetic medicines for rare and complex diseases.
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Get Splice Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Splice Bio? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Splice Bio in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access